Dr. David Hellerstein, a professor of clinical psychiatry, spoke about the potential upsides of a new nasal spray that has shown promise in a trial of people with treatment-resistant depression.
Ryan Sultan, MD is concerned about the lack of data on cannabis. "We don’t know what doses are appropriate, what their long-term effects are or even what people are consuming," he says.
A potential vaccine for opioid addiction/overdose prevention has begun Phase 1 clinical trials on humans with research led by Sandra Comer, a professor of neurobiology (in psychiatry) at Columbia.
Smithers Center at Columbia University Irving Medical Center provides evidence-based care to individuals seeking treatment for substance use disorders and co-occurring mental health conditions.
Dr. Madelyn Gould recommends screening individuals for suicide risk and postvention/crisis intervention after a suicide to minimize and contain the effects of suicide contagion.
"It's very rare to see a suicide, death, or even an attempt outside the context of a psychiatric illness, half the time that illness is a depression," said Dr. John Mann.
“More and more, people see [attachment as] less categorical and more on a spectrum,” said Dr. Amir Levine, associate professor of clinical psychiatry at Columbia.
